ARTICLE
5 August 2015

FDA Authorizes Emergency Use Of In Vitro Diagnostic Device For Enterovirus D68

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
The EUA was issued pursuant to the FDCA at the request of the Centers for Disease Control and Preventions.
United States Food, Drugs, Healthcare, Life Sciences

In the July 1, 2015, Federal Register, FDA announced the issuance of an Emergency Use Authorization ("EUA") for an in vitro diagnostic device to detect Enterovirus D68 strains observed in North America in 2014. The EUA was issued pursuant to the FDCA at the request of the Centers for Disease Control and Preventions.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More